Suppr超能文献

真菌跨界动态与溃疡性结肠炎对粪便微生物群移植 (FMT) 治疗的反应性相关。

Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.

机构信息

Gastroenterology and Hepatology Division, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.

University of New South Wales, Sydney NSW 2052, Australia; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.

出版信息

Cell Host Microbe. 2020 May 13;27(5):823-829.e3. doi: 10.1016/j.chom.2020.03.006. Epub 2020 Apr 15.

Abstract

Fecal microbiota transplantation (FMT) targeting gut microbiota has recently been successfully applied to ulcerative colitis. However, only a subset of patients responds to FMT, and there is a pressing need for biomarkers of responsiveness. Fungi (the mycobiota) represent a highly immunologically reactive component of the gut microbiota. We analyzed samples from a large randomized controlled trial of FMT for ulcerative colitis (UC). High Candida abundance pre-FMT was associated with a clinical response, whereas decreased Candida abundance post-FMT was indicative of ameliorated disease severity. High pre-FMT Candida was associated with increased bacterial diversity post-FMT, and the presence of genera was linked to FMT responsiveness. Although we detected elevated anti-Candida antibodies in placebo recipients, this increase was abrogated in FMT recipients. Our data suggest that FMT might reduce Candida to contain pro-inflammatory immunity during intestinal disease and highlight the utility of mycobiota-focused approaches to identify FMT responders prior to therapy initiation.

摘要

粪便微生物群移植(FMT)针对肠道微生物群,最近已成功应用于溃疡性结肠炎。然而,只有一部分患者对 FMT 有反应,因此迫切需要反应性生物标志物。真菌(真菌群)是肠道微生物群中具有高度免疫反应性的组成部分。我们分析了来自溃疡性结肠炎(UC)FMT 的大型随机对照试验的样本。FMT 前高假丝酵母菌丰度与临床反应相关,而 FMT 后假丝酵母菌丰度降低则表明疾病严重程度得到改善。FMT 前高假丝酵母菌与 FMT 后细菌多样性增加相关,并且某些属的存在与 FMT 反应性相关。尽管我们在安慰剂组中检测到了升高的抗假丝酵母菌抗体,但在 FMT 组中这种增加被消除了。我们的数据表明,FMT 可能会降低假丝酵母菌以控制肠道疾病中的促炎免疫,并强调了专注于真菌群的方法在治疗前识别 FMT 反应者的实用性。

相似文献

1
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.
Cell Host Microbe. 2020 May 13;27(5):823-829.e3. doi: 10.1016/j.chom.2020.03.006. Epub 2020 Apr 15.
4
Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
Front Cell Infect Microbiol. 2023 Jan 5;12:1086885. doi: 10.3389/fcimb.2022.1086885. eCollection 2022.
8
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.
9
Fecal microbiota transplantation for ulcerative colitis.
Immunol Med. 2021 Mar;44(1):30-34. doi: 10.1080/25785826.2020.1792040. Epub 2020 Jul 14.
10

引用本文的文献

1
The Human Mycobiome: Composition, Immune Interactions, and Impact on Disease.
Int J Mol Sci. 2025 Jul 28;26(15):7281. doi: 10.3390/ijms26157281.
3
Live strains from the mucosa of patients with ulcerative colitis: pathogenic potential and environmental adaptations.
mBio. 2025 Jul 9;16(7):e0140025. doi: 10.1128/mbio.01400-25. Epub 2025 Jun 13.
4
Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases.
Gut Microbes. 2025 Dec;17(1):2508426. doi: 10.1080/19490976.2025.2508426. Epub 2025 Jun 4.
6
The Role of Intestinal Fungi in the Pathogenesis and Treatment of Ulcerative Colitis.
Microorganisms. 2025 Mar 31;13(4):794. doi: 10.3390/microorganisms13040794.
8
The Gut Mycobiome for Precision Medicine.
J Fungi (Basel). 2025 Apr 2;11(4):279. doi: 10.3390/jof11040279.
9
Unveiling the fungal frontier: mycological insights into inflammatory bowel disease.
Front Immunol. 2025 Mar 26;16:1551289. doi: 10.3389/fimmu.2025.1551289. eCollection 2025.
10
Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay.
Front Microbiol. 2025 Mar 25;16:1556827. doi: 10.3389/fmicb.2025.1556827. eCollection 2025.

本文引用的文献

1
Outbreak of Electronic-Cigarette-Associated Acute Lipoid Pneumonia - North Carolina, July-August 2019.
MMWR Morb Mortal Wkly Rep. 2019 Sep 13;68(36):784-786. doi: 10.15585/mmwr.mm6836e1.
2
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
Lancet. 2019 Aug 3;394(10196):420-431. doi: 10.1016/S0140-6736(19)31266-8.
3
Moving beyond P values: data analysis with estimation graphics.
Nat Methods. 2019 Jul;16(7):565-566. doi: 10.1038/s41592-019-0470-3.
4
Gut Mycobiota in Immunity and Inflammatory Disease.
Immunity. 2019 Jun 18;50(6):1365-1379. doi: 10.1016/j.immuni.2019.05.023.
5
Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models.
Cell Host Microbe. 2019 Mar 13;25(3):377-388.e6. doi: 10.1016/j.chom.2019.01.007. Epub 2019 Mar 5.
6
Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium.
PLoS One. 2019 Jan 15;14(1):e0210798. doi: 10.1371/journal.pone.0210798. eCollection 2019.
8
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.
9
Response to Fungal Dysbiosis by Gut-Resident CX3CR1 Mononuclear Phagocytes Aggravates Allergic Airway Disease.
Cell Host Microbe. 2018 Dec 12;24(6):847-856.e4. doi: 10.1016/j.chom.2018.11.003. Epub 2018 Nov 29.
10
Fecal transplantation for treatment of inflammatory bowel disease.
Cochrane Database Syst Rev. 2018 Nov 13;11(11):CD012774. doi: 10.1002/14651858.CD012774.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验